Abstract 1141: The CoREST complex as a novel target to disrupt AT/RT’s abnormal epigenetic landscape
Anupa Geethadevi(Bloomberg (United States)), Jeffrey Rubens(Johns Hopkins University), Marianne Collard(Boston University), Eric H. Raabe(Johns Hopkins University), Kristen Malebranche(Johns Hopkins University), Rhoda M. Alani(Boston University), Nikhil Vaidya(Boston University), Philip Cole(Brigham and Women's Hospital), Tyler Findlay(Johns Hopkins University), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711